AbbVie Inc. vs Renascience Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $163 M for Renascience Inc., 3153 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Mar 8, 2026 for Renascience Inc.). Renascience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | Renascience Inc. 4889.T |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇯🇵 Japan |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 2013 | — |
| Size | ||
| Market cap | $514.0 B | $163 M* |
| Revenue | $61.2 B | — |
| Net income | $4.2 B | — |
| Employees | 57,000 | — |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2% | — |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | — |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6% | — |
| Revenue growth, 3 years a year | 1.8% | — |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Mar 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or Renascience Inc.?
AbbVie Inc. is the larger company by market value: $514.0 B against $163 M for Renascience Inc., 3153 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Mar 8, 2026 for Renascience Inc.). Renascience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
More about AbbVie Inc.
More about Renascience Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.